Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Reinsurance Group (NYSE:RGA) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $238.0, with a high estimate of $261.00 and a low estimate of $223.00. This current average has increased by 5.43% from the previous average price target of $225.75.

The perception of Reinsurance Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Nigel Dally | Morgan Stanley | Raises | Equal-Weight | $223.00 | $208.00 |
| Wesley Carmichael | Wells Fargo | Raises | Overweight | $261.00 | $238.00 |
| Elyse Greenspan | Wells Fargo | Raises | Overweight | $238.00 | $237.00 |
| John Barnidge | Piper Sandler | Raises | Overweight | $230.00 | $220.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Reinsurance Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Reinsurance Group analyst ratings.
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Reinsurance Group's remarkable performance in 3M is evident. As of 31 December, 2025, the company achieved an impressive revenue growth rate of 6.52%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Reinsurance Group's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 6.98%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Reinsurance Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.5%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Reinsurance Group's ROA excels beyond industry benchmarks, reaching 0.3%. This signifies efficient management of assets and strong financial health.
Debt Management: Reinsurance Group's debt-to-equity ratio stands notably higher than the industry average, reaching 0.42. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.